Outcomes and risk factors of SARS‐CoV‐2 omicron variant in B‐cell lymphoma patients following CD19 targeted CAR‐T therapy

Outcomes and risk factors of SARS‐CoV‐2 omicron variant in B‐cell lymphoma patients following CD19 targeted CAR‐T therapy

Abstract Background Little was known on infection and mortality rates, still less the risk factors of severe acute respiratory syndrome coronavirus 2 (SARS‐CoV‐2) omicron variant in B‐cell lymphoma patients following CD19 targeted chimeric antigen receptor T cell (CAR‐T). Aims We performed a retrosp...

Full description

Bibliographic Details
Main Authors: Xibin Xiao, Panpan Chen, Yadi Zhong, Xiu Luo, Yao Liu, Ying Lu, Xueli Jin, Wenbin Qian, Weidong Han, Aibin Liang, Hui Liu
Format: Article
Language:English
Published: Wiley 2023-11-01
Series:Cancer Medicine
Subjects:
B‐cell lymphoma
chimeric antigen receptor T cell
omicron variant
outcome
severe acute respiratory syndrome coronavirus 2
Online Access:https://doi.org/10.1002/cam4.6657

Internet

https://doi.org/10.1002/cam4.6657

Similar Items